Anti-Emetics Will Get Separate Payment Codes Under Medicare Outpatient Rule

Aventis' Anzemet, Roche's Kytril and GlaxoSmithKline's Zofran would be paid separately rather than packaged with other therapeutic services under proposed rule. Reimbursement for MGI's Aloxi will equal new ASP-based payments for physicians in the office setting.